Upper Airway Stimulation

What upper airway stimulation is

Upper airway stimulation (UAS) treats obstructive sleep apnea with a small implanted device that gently stimulates the nerve controlling the tongue during sleep, keeping the airway from collapsing. Rather than splinting the airway open with air pressure (CPAP) or holding the jaw forward (an oral appliance), it works from the inside: the device senses your breathing and, with each breath, delivers a mild impulse to the hypoglossal nerve that moves the tongue slightly forward and clears the airway. The best-known example is the Inspire device.

The system has a few parts placed during a single surgery: a small generator implanted under the skin of the chest (similar in concept to a pacemaker), a lead that senses your breathing, and a lead that stimulates the nerve. You turn it on with a small handheld remote when you go to sleep and off when you wake. There is no mask, no hose, and nothing in your mouth — once it is implanted and tuned, the therapy runs quietly on its own through the night.

It is important to be clear about where UAS sits: it is not a first-line treatment and not for everyone with sleep apnea. It is a later-tier option, reserved for selected patients with moderate-to-severe obstructive sleep apnea who have not been able to tolerate CPAP and who meet specific candidacy criteria. For the right person, it can be a genuinely life-changing therapy; the work is in identifying who that right person is.

Who qualifies

Upper airway stimulation has the tightest candidacy requirements of the common sleep apnea therapies, by design. Because it involves surgery and an implanted device, the bar for offering it is deliberately high, and several gates have to be cleared.

CPAP has to have failed first. The entry point is documented moderate-to-severe obstructive sleep apnea together with a genuine inability to tolerate CPAP — UAS is positioned as an option for people CPAP has let down, not as a way to skip trying it. Working through the common, fixable causes of CPAP intolerance usually comes first.

The apnea has to be the right type and severity. Candidacy centers on moderate-to-severe obstructive apnea within established criteria. Body weight is part of the assessment, because the therapy performs best within a certain range. These thresholds are set by the evidence and confirmed by the evaluating specialist.

The airway has to collapse in a treatable pattern. This is the distinctive screening step: before implantation, a drug-induced sleep endoscopy (DISE) is performed — a brief procedure in which you are lightly sedated to mimic sleep while a specialist views how your airway collapses. The device works well for certain collapse patterns and not for others (notably, a particular complete circular collapse at the palate predicts a poor response). DISE identifies who will actually benefit, which is why it is a required part of the workup rather than an optional extra.

Each of these gates exists for a concrete reason. The CPAP-first requirement reflects that CPAP, when tolerated, is more effective and far less invasive, so it should be genuinely tried before turning to surgery. The severity and weight criteria reflect where the evidence shows the therapy performs — it is not designed for mild apnea, and response falls off outside the studied weight range. And the endoscopy requirement reflects the simple fact that a device that moves the tongue forward can only help if tongue-base collapse is actually part of your problem. Taken together, the criteria are less a series of hurdles than a filter that concentrates the therapy on the people it reliably helps — which is exactly why the published outcomes for well-selected patients are as good as they are. If you do not pass one of the gates, that is the evaluation doing its job, sparing you a major procedure unlikely to deliver.

How well it works

In the well-selected patients UAS is designed for, the results are strong. Among people who clear the candidacy and screening gates, upper airway stimulation produces substantial reductions in the apnea-hypopnea index, meaningful improvements in daytime sleepiness and quality of life, and — importantly — high real-world use, because there is no mask to tolerate and nothing to wear. Once it is implanted and tuned, using it is as simple as pressing a button at bedtime, and that low burden translates into consistent nightly therapy.

The honest framing is that UAS trades breadth for fit. It is not as broadly applicable as CPAP, which can treat nearly anyone at the right pressure; a meaningful share of people who want UAS will not qualify, and not everyone who qualifies responds completely. But within its intended population — moderate-to-severe OSA, CPAP-intolerant, with a treatable collapse pattern — it is a highly effective therapy with durable results, and the careful screening is precisely what makes the outcomes good. It is a narrow door that opens onto a genuinely effective treatment.

As with any sleep apnea therapy, the result is confirmed objectively rather than assumed. After the device is activated and titrated, follow-up sleep testing verifies that the apnea is actually controlled, and the stimulation settings can be adjusted over time to optimize the response.

One of the therapy's genuine strengths is durability. Because the benefit does not depend on tolerating a mask night after night, the response tends to hold up over the long term in patients who were good candidates to begin with — the device keeps working the same way whether it is night one or year five, and the consistent nightly use that makes it effective does not erode the way mask adherence sometimes does. That durability, combined with the low daily effort, is much of what makes it worth the surgical commitment for the right person. The flip side is the same point from the other direction: because so much rides on patient selection, the screening is not bureaucratic caution — it is the single biggest determinant of whether the therapy will deliver, which is why a thorough evaluation before committing to surgery is in your interest, not an obstacle to it.

The pathway: from candidacy to a working device

Getting to upper airway stimulation is a multi-step process, and each step is a checkpoint that confirms the therapy is right for you before moving to the next.

The sequence is deliberate. CPAP intolerance establishes the need; candidacy screening and the drug-induced sleep endoscopy confirm that you are likely to benefit; the implant procedure places the device; and activation weeks later — after the surgical sites have healed — begins the tuning process. None of these steps is skippable, and the screening in particular is what separates good outcomes from disappointing ones.

The procedure and recovery

The implantation is an outpatient surgical procedure, typically performed under general anesthesia and usually completed in a few hours, with most people going home the same day. The surgeon places the generator under the skin of the upper chest and positions the sensing and stimulation leads. As with any surgery, there is a recovery period: some soreness and swelling at the incision sites that settles over the following days to weeks, with activity restrictions during initial healing.

A point that surprises many people: the device is not turned on right away. It stays off while the surgical sites heal — generally several weeks — and is then activated at a follow-up visit. From there, the stimulation level is titrated over subsequent visits to find the setting that controls the apnea comfortably without disrupting your sleep, much as an oral appliance is titrated or a CPAP pressure is dialed in. The therapy becomes "set and forget" only after this tuning period.

Day to day, living with the device is low-effort: you press a button on a small remote to turn it on at bedtime and off in the morning, and there is nothing to clean, refill, or pack for travel beyond the remote. Periodic check-ups confirm the device is working and allow setting adjustments over time.

Trade-offs and considerations

The defining trade-off of upper airway stimulation is right at the front: it is a surgical procedure that places a permanent implant, which is a fundamentally bigger commitment than putting on a mask or a mouthpiece. That carries the general risks of surgery and anesthesia, the possibility of discomfort or sensation from the stimulation that needs adjusting, and the reality that the device is something inside your body that may eventually need maintenance or battery replacement over the years.

There are practical considerations too: the candidacy and screening process is involved and not everyone passes it, the procedure and device represent a significant medical intervention typically pursued through specialized centers, and — like all the alternatives — it is appropriate for specific situations rather than as a default. Some people also find the stimulation sensation takes adjustment, which the titration process addresses.

Set against those considerations is the comparison that matters: for someone with moderate-to-severe obstructive sleep apnea who genuinely cannot use CPAP, the alternative is often untreated apnea, with its substantial cardiovascular and cognitive consequences. For the right candidate, an implanted therapy they will actually use every night can be far better than an effective machine they cannot tolerate. That is the equation UAS is meant to solve, and why it exists as an option at all.

What it costs and how it's covered

Upper airway stimulation is a significant medical intervention, and the cost reflects that: it involves a surgical procedure, an implanted device, and a workup that includes the screening drug-induced sleep endoscopy. The total cost of the device and procedure is substantial — well beyond CPAP or an oral appliance — which is part of why it is reserved for defined situations rather than offered broadly.

The encouraging side is that, for appropriate candidates, it is widely covered. In the United States, Medicare and many private insurers cover upper airway stimulation when the established criteria are met — typically documented moderate-to-severe OSA, demonstrated CPAP intolerance, a body weight within range, and a favorable airway assessment on sleep endoscopy. Those same candidacy gates that determine whether the therapy will work also tend to be what coverage hinges on, so the evaluation does double duty: it confirms you are likely to benefit and it builds the documentation insurers require. Prior authorization is the norm given the cost, and the specialized centers that perform the procedure are generally experienced at navigating it. The structural picture — strict medical-necessity criteria, prior authorization, documentation of failed prior therapy — applies internationally even where specific programs differ.

The practical step is to have the candidacy conversation first; if you clear the clinical gates, the same evaluation that establishes candidacy is usually what supports coverage. For how testing, treatment, and equipment are organized and paid for more broadly, see sleep care explained.

Upper airway stimulation, CPAP, or an oral appliance

Upper airway stimulation is one of several options for obstructive sleep apnea, sitting in a later tier than the front-line therapies. Seeing them side by side clarifies where it fits.

CPAP remains the most effective and most broadly applicable therapy, and the standard first recommendation. Oral appliance therapy is the leading non-invasive alternative, especially for mild-to-moderate disease and for CPAP-intolerant moderate cases. Upper airway stimulation occupies the next tier: for selected moderate-to-severe patients who have exhausted the front-line options and meet the candidacy and screening criteria, it offers an effective, low-daily-burden therapy at the cost of a surgical procedure. Some upper-airway surgeries to alter anatomy directly occupy a similar later-tier role for patients with specific structural obstruction. The decision among these is made with a sleep specialist and, for the surgical options, a surgeon — based on objective testing and individual anatomy, not on preference alone.

When to talk to your doctor

Upper airway stimulation is a specialist-level decision, and the path to it runs through a sleep physician. If you have moderate-to-severe obstructive sleep apnea and have honestly been unable to tolerate CPAP despite working at it, that is the conversation to have: ask your sleep specialist whether you might be a candidate for upper airway stimulation, and what the evaluation would involve.

Be prepared for the answer to be "let's find out" rather than "yes" — the candidacy screening and drug-induced sleep endoscopy exist precisely because not everyone is a fit, and that screening protects you from a procedure unlikely to help. If you are not a candidate, your specialist can point you toward other options, including oral appliance therapy or renewed efforts with CPAP, because the goal is always an effective, consistently used treatment rather than a particular device.

If you have not yet been diagnosed or are unsure of your severity, start there. The free Sleep Score screener can help you gauge your apnea risk and point you toward the right next step, and untreated obstructive sleep apnea is worth addressing one way or another — the cardiovascular and daytime consequences make some effective therapy, consistently used, the real objective.